GL1X · GenesisL1 explorer

Research workbench

Co-crystal structure of inhibitor compound ma-211 in complex with human ppardelta lbd

Analyse Co-crystal structure of inhibitor compound ma-211 in complex with human… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7F80
Type
protein
Length
509 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q03181
Ligands
1KF

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein255—Q03181
B—protein254—Q03181

Ligands and binding sites

  • 1KF · (3R)-3-methyl-6-[2-[[5-methyl-2-[4-(trifluoromethyl) phenyl]imidazol-1-yl]methyl]phenoxy]hexanoic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7F80 · Co-crystal structure of Inhibitor compound MA-211 in complex with human PPARdelta LBD · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.